Company news
Bionik Laboratories Corp. (OTC:BNKL) news
Bionik Laboratories Corp. news releases on 6ix. Latest, Aug 10, 2022: BIONIK Laboratories Reports First Quarter Financial Results
Press releases & updates
BIONIK Laboratories Reports First Quarter Financial Results
August 10, 2022
BIONIK Laboratories Corp. to Present at Investor Summit Group’s Q3 Virtual Conference
August 9, 2022
BIONIK Laboratories Announces the Sale & Installation of a New InMotion® ARM/HAND Robotic Device to Tampa General Hospital for its Rehabilitation Center
June 23, 2022
BIONIK Laboratories Reports Fourth Quarter and Fiscal Year 2022 Financial Results
June 9, 2022
BIONIK Laboratories to Attend the 2022 American Occupational Therapy Association (AOTA) Conference & Expo
March 30, 2022
BIONIK Laboratories Reports 15-20% Increase in Therapeutic Gains on InMotion® Robotic Devices in New Patient Outcomes Data Report
March 29, 2022
BIONIK Laboratories Reports Third Quarter Fiscal Year 2022 Financial Results
February 9, 2022
BIONIK Laboratories to Participate at the American Physical Therapy Association Conference
January 31, 2022
BIONIK Laboratories to Participate at MEDICA, a Leading International Trade Show for the Medical Industry
November 11, 2021
BIONIK Laboratories Reports Second Quarter Fiscal Year 2022 Financial Results
November 10, 2021
BIONIK Laboratories Announces Commercial Team Addition With Newly Hired Regional Sales Director, Tony Bellofatto
October 28, 2021
BIONIK Laboratories Reports a 72% Increase in Patient Sessions on its InMotion® Robotic Devices Since Launch of InMotion Connect™ Platform
September 22, 2021
BIONIK Laboratories Reports Fiscal 2022 Q1 Financial Results
August 12, 2021
BIONIK Laboratories Announces $5 Million Capital Raise through Issuance of Convertible Notes
July 29, 2021
BIONIK Laboratories Announces Resignation of CEO, Names Interim CEO
July 19, 2021
BIONIK Laboratories Reports Fiscal 2021 Financial Results
June 24, 2021
BIONIK Laboratories Reports Fiscal 2021 Q3 Financial Results
February 11, 2021
BIONIK Laboratories Corp. Appoints Rich Russo, Jr. as CFO
November 30, 2020
BIONIK Laboratories Announces Fiscal 2021 Q2 Financial Results
November 12, 2020
BIONIK Laboratories Announces Sale of New InMotion® ARM/HAND Robotic Device to VA Rehabilitation Research & Development’s Center for Neurorestoration and Neurotechnology
September 30, 2020
BIONIK Laboratories Announces Fiscal 2021 Q1 Financial Results
August 13, 2020
BIONIK Laboratories Announces Fiscal 2020 Financial Results
June 30, 2020
BIONIK Laboratories Launches InMotion Connect™, Driving Outcomes through Internet of Things (IoT) and Intelligent Data
June 25, 2020
BIONIK Laboratories Donates InMotion® Robotic System to Einstein Healthcare Network’s MossRehab for Use in New COVID-19 Rehab Unit
May 12, 2020
BIONIK Laboratories Announces Third Quarter Fiscal 2020 Financial Results
February 14, 2020
BIONIK Laboratories Announces Regulatory Approval and First Sale of its InMotion® ARM Robotic Technology by its Exclusive Distributor in South Korea
January 30, 2020
BIONIK Laboratories Selects Propel to Accelerate New Product Development and Manufacturing of InMotion Robotic Systems and Services
December 10, 2019
BIONIK Laboratories Announces Second Quarter Fiscal 2020 Financial Results
November 15, 2019
BIONIK Laboratories Partners with Intelliware Development to Provide Seamless Connectivity Between InMotionTM Robotic Devices and Hospital Information Systems
October 14, 2019
BIONIK Laboratories Appoints Loren Wass as Chief Commercial Officer
September 4, 2019
BIONIK Laboratories’ Fiscal Year 2020 Q1 Financial Results Feature 57% Increase in Sales
August 13, 2019
BIONIK Laboratories’ Fiscal 2019 Financial Results Feature 229% Increase in Sales
July 2, 2019
Landmark RATULS Research Trial of Robot-Assisted Stroke Therapy Utilizes BIONIK’s InMotion Robotic Therapy Systems
May 28, 2019
BIONIK Laboratories Third Quarter Fiscal 2019 Financial Results Feature 256% Increase in Sales
February 11, 2019
BIONIK Laboratories Launches Next-Generation InMotion ARM/HAND Robotic System to Improve Rehabilitation for Stroke Survivors
January 23, 2019
BIONIK Laboratories Announces Multi-Year Purchase Agreement and Ongoing Relationship with Kindred Hospital Rehabilitation Services for InMotion Arm™ Robotic Systems
December 17, 2018
BIONIK Laboratories Second Quarter Fiscal 2019 Financial Results Feature 147% Increase in Revenues
November 13, 2018
Bionik Laboratories Announces 1-for-150 Reverse Stock Split
October 29, 2018
BIONIK Laboratories Announces Purchase Agreement from Clinique Les Trois Soleils for InMotion Arm™ Robotic System
October 24, 2018
Bionik Laboratories Appoints Dr. Audrey D. Thévenon and Charles Matine to its Board of Directors
September 13, 2018
Bionik Laboratories Reports First Quarter Fiscal 2019 Financial Results
August 14, 2018
Bionik Laboratories Reports Fiscal Year 2018 Financial Results
June 27, 2018
Bionik Laboratories Announces Agreement with The Transitional Learning Center for InMotion Arm Robotic Systems
June 21, 2018
Bionik Laboratories Appoints Renaud Maloberti as Chief Commercial Officer
June 11, 2018
Bionik Laboratories Announces Rental Agreement with Tallahassee Memorial HealthCare for InMotion Arm Robotic System
May 16, 2018
Bionik Laboratories Issues Letter to Stockholders
April 3, 2018
Bionik Laboratories Appoints Peter Gerald Malone and Joseph Martin to its Board of Directors
March 20, 2018
Bionik Laboratories Corp. and Curexo Enter Exclusive Distribution Agreement for Sale of Robotic Rehabilitation Systems in U.S. and South Korea
March 7, 2018
Bionik Laboratories Reports Third Quarter Fiscal Year 2018 Financial Results
February 13, 2018
Bionik Laboratories Corp. Launches New Commercial Generation InMotion Arm Robotic System to Improve Rehabilitation for Stroke Survivors
February 5, 2018